Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 21, 2020

View Archived Issues

Benzoxazole analogues capable of reducing ChemR23 expression on monkey pDCs in vivo

ImmTAV molecules redirect T cells to lyse HBV DNA-integrated and virally infected cells in vitro

New phase II trial opens in France to study XAV-19 in COVID-19-induced moderate pneumonia

Athira opens enrollment in phase II trial of ATH-1017 for mild to moderate Alzheimer's

First-in-human study of progerinin

Discovery of novel potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors

Inhibition of alpha-KG-producing enzymes is therapeutic in diffuse intrinsic pontine glioma models

Novel FARS2 gene mutation causes spastic paraplegia 77

Tissue-specific p53 effects could aid drug development

Merck KGaA divulges PTPN11 inhibitors

Chinese researchers disclose ENPP2 inhibitors

Sunshine Lake Pharma patent reveals influenza virus replication inhibitors

1st Bio Therapeutics identifies ABL1 inhibitors

ADC Therapeutics starts enrollment in phase III study of loncastuximab tesirine in DLBCL

Optikira synthesizes new ERN1 inhibitors

Phase I/IIa data published for BIVV-001 in patients with hemophilia A

Ascletis begins phase I study of ASC-41 in healthy subjects

Akeso begins first-in-human study of COVID-19 treatment candidate AK-119

CIP2A as new diagnostic biomarker in Parkinson's disease

SAGE-718 studied in phase II for Parkinson's disease mild cognitive impairment

New antibody-mediated multiple sclerosis model developed

Confirmatory phase III trial of Pacev in urothelial cancer meets primary endpoint of OS

Shanghai Henlius Biotech begins phase I study with pertuzumab biosimilar HLX-11

APPA enters phase II trial for osteoarthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...